Risk-adapted treatment of acute promyelocytic leukemia with all-trans retinoic acid and anthracycline monochemotherapy: long-term outcome of the LPA 99 multicenter study by the PETHEMA Group.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples